↓ Skip to main content

Long-term Safety and Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: The JUPITER Study

Overview of attention for article published in Advances in Therapy, July 2016
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news
10 news outlets
twitter
1 X user

Citations

dimensions_citation
63 Dimensions

Readers on

mendeley
60 Mendeley
Title
Long-term Safety and Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: The JUPITER Study
Published in
Advances in Therapy, July 2016
DOI 10.1007/s12325-016-0385-7
Pubmed ID
Authors

Kazuhide Kawase, Jason L. Vittitow, Robert N. Weinreb, Makoto Araie, For the JUPITER Study Group

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 60 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 60 100%

Demographic breakdown

Readers by professional status Count As %
Other 9 15%
Researcher 8 13%
Student > Ph. D. Student 6 10%
Student > Doctoral Student 4 7%
Student > Master 4 7%
Other 9 15%
Unknown 20 33%
Readers by discipline Count As %
Medicine and Dentistry 16 27%
Pharmacology, Toxicology and Pharmaceutical Science 6 10%
Nursing and Health Professions 5 8%
Biochemistry, Genetics and Molecular Biology 3 5%
Agricultural and Biological Sciences 3 5%
Other 4 7%
Unknown 23 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 79. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 April 2024.
All research outputs
#549,521
of 25,837,817 outputs
Outputs from Advances in Therapy
#60
of 2,677 outputs
Outputs of similar age
#11,000
of 385,092 outputs
Outputs of similar age from Advances in Therapy
#3
of 52 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,677 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.1. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 385,092 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 52 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.